Mr Walynn C Smith, LPT | |
4000 Central Ave, Suite #3, Cheyenne, WY 82001-1376 | |
(307) 634-0298 | |
(307) 634-0837 |
Full Name | Mr Walynn C Smith |
---|---|
Gender | Male |
Speciality | Physical Therapist |
Location | 4000 Central Ave, Cheyenne, Wyoming |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1780632794 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
225100000X | Physical Therapist | 160 (Wyoming) | Primary |
Mailing Address | Practice Location Address |
---|---|
Mr Walynn C Smith, LPT 4000 Central Ave, Suite #3, Cheyenne, WY 82001-1376 Ph: (307) 634-0298 | Mr Walynn C Smith, LPT 4000 Central Ave, Suite #3, Cheyenne, WY 82001-1376 Ph: (307) 634-0298 |
News Archive
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering breakthrough treatments for human disease, announced data from a recently completed clinical trial and mechanistic study of a solid oral dose formulation for LX4211, a dual inhibitor of sodium-glucose co-transporters 1 and 2 (SGLT1 and SGLT2).
Two to three in every 1,000 children are born with a hearing loss that is likely to impact development. Research of the auditory system at its early developmental stages, and efforts to identify hearing loss and initiate appropriate rehabilitation strategies, can be crucial to the healthy development of a child.
A tiny protein called ubiquitin - so named because it is present in every cell of living things as dissimilar as hollyhocks and humans - may hold the key to treatment for a variety of diseases from Parkinson's to diabetes.
Results from a phase III clinical trial evaluating a new treatment for breast cancer in post-menopausal women show that the combination of two cancer drugs, everolimus and exemestane, significantly improves bone strength and reduces the chances of cancer spreading (metastasising) in the bone.
An advisory committee recommended today that the Food and Drug Administration (FDA) approve QAB149 (indacaterol) 75 mcg in the US as a once-daily long-term maintenance bronchodilator treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema.
› Verified 7 days ago
Bluegrass Physical Therapy Limited Partnership Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1950 Bluegrass Cir, Suite 110, Cheyenne, WY 82009 Phone: 307-634-2626 Fax: 307-634-5099 | |
Mrs. Linda Rc Froelicher, MSPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 4000 Central Ave, Suite #3, Cheyenne, WY 82001 Phone: 307-634-0298 Fax: 307-634-0837 | |
Nicholas Robert Johnson, PT, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1900 Converse Ave Ste B, Cheyenne, WY 82001 Phone: 307-514-2411 Fax: 307-514-2392 | |
Byron Louis Long, MPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1950 Bluegrass Cir, Suite 110, Cheyenne, WY 82009 Phone: 307-634-2626 Fax: 307-634-5099 | |
Mr. Thomas James Bledsoe, M.P.T. Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 4017 Rawlins St, Cheyenne, WY 82001 Phone: 307-635-2562 | |
Sandra Champlin, PT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 1951 Bluegrass Cir, Cheyenne, WY 82009 Phone: 307-773-8533 Fax: 307-635-7578 | |
Dr. Charlene Marie Sheamansmith, PT, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 4515 E Pershing Blvd Unit C, Cheyenne, WY 82001 Phone: 307-635-2388 Fax: 307-635-1730 |